The treatment of arterial hypertension in patient with myocardial infaction in recent history, the percutaneous coronary intervention is just the beginning
Abstract
Increased activity of the sympathetic nervous system as well as increased activity of the renin-angiotensin-aldosterone system (RAAS) constitute the pathophysiological basis of the most common cardiac diseases - arterial hypertension, ischemic heart disease and chronic heart failure. According to this, beta-blockers and angiotensin-converting enzyme inhibitors are recommended in the treatment of all these diseases.
The short case report demonstrates the case of a patient with acute coronary syndrome treated by percutaneous coronary intervention. After discharge from the hospital, consistent intervention of all cardiovascular risk factors is necessary, regular monitoring of blood pressure and lipid profile as well as anti-smoking intervention and monitoring of heart rate.
Higher heart rate in hypertensive patients is considered to be another independent risk factor for cardiovacular diseases. During the treatment, according to the Guidelines of the European Society of Cardiology for the Prevention of Cardiovascular Diseases, fixed combinations should be preferred and used whenever a suitable combination in a fixed variant is available.